Gene · 407034
Papers2,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of Nurr1-miR-30e-5p-NLRP3 axis in inflammation-mediated neurodegeneration: insights from mouse models and patients' studies in Parkinson's disease. | J Neuroinflammation | 2023 | 37990334 | PubTator, text mining | PubMed |
| Novel mediator in anaphylaxis: decreased levels of miR-375-3p in serum and within extracellular vesicles of patients. | Front Immunol | 2023 | 37965316 | PubTator, text mining | PubMed |
| Unraveling the Intricate Roles of Exosomes in Cardiovascular Diseases: A Comprehensive Review of Physiological Significance and Pathological Implications. | Int J Mol Sci | 2023 | 37958661 | PubTator, text mining | PubMed |
| The Arising Role of Extracellular Vesicles in Cholangiocarcinoma: A Rundown of the Current Knowledge Regarding Diagnostic and Therapeutic Approaches. | Int J Mol Sci | 2023 | 37958547 | PubTator, text mining | PubMed |
| Atherosclerosis and Its Related Laboratory Biomarkers. | Int J Mol Sci | 2023 | 37958528 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker. | Cancers (Basel) | 2023 | 37958409 | PubTator, text mining | PubMed |
| DARS2 promotes the occurrence of lung adenocarcinoma via the ERK/c-Myc signaling pathway. | Thorac Cancer | 2023 | 37950542 | PubTator, text mining | PubMed |
| Epigenetic modulations of immune cells: from normal development to tumor progression. | Int J Biol Sci | 2023 | 37928272 | PubTator, text mining | PubMed |
| Small RNAs, spermatogenesis, and male infertility: a decade of retrospect. | Reprod Biol Endocrinol | 2023 | 37924131 | PubTator, text mining | PubMed |
| Early to sustained impacts of lethal radiation on circulating miRNAs in a minipig model. | Sci Rep | 2023 | 37898651 | PubTator, text mining | PubMed |
| CeRNA Network Reveals the Circular RNA Characterization in Goat Ear Fibroblasts Reprogramming into Mammary Epithelial Cells. | Genes (Basel) | 2023 | 37895180 | PubTator, text mining | PubMed |
| Circulating microRNA Panels for Detection of Liver Cancers and Liver-Metastasizing Primary Cancers. | Int J Mol Sci | 2023 | 37895131 | PubTator, text mining | PubMed |
| 3'IsomiR Species Composition Affects Reliable Quantification of miRNA/isomiR Variants by Poly(A) RT-qPCR: Impact on Small RNA-Seq Profiling Validation. | Int J Mol Sci | 2023 | 37895116 | PubTator, text mining | PubMed |
| In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer. | Biomedicines | 2023 | 37893081 | PubTator, text mining | PubMed |
| PIK3CD correlates with prognosis, epithelial-mesenchymal transition and tumor immune infiltration in breast carcinoma. | Discov Oncol | 2023 | 37861728 | PubTator, text mining | PubMed |
| miRNA Studies in Glaucoma: A Comprehensive Review of Current Knowledge and Future Perspectives. | Int J Mol Sci | 2023 | 37834147 | PubTator, text mining | PubMed |
| The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives. | Front Clin Diabetes Healthc | 2023 | 37822556 | PubTator, text mining | PubMed |
| miRNAs from Inflamed Gingiva Link Gene Signaling to Increased MET Expression. | J Dent Res | 2023 | 37822091 | PubTator, text mining | PubMed |
| Retracted: Circular RNA circFAT1(e2) Promotes Colorectal Cancer Tumorigenesis via the miR-30e-5p/ITGA6 Axis. | Comput Math Methods Med | 2023 | 37799424 | PubTator, text mining | PubMed |
| Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer. | Theranostics | 2023 | 37771767 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407034/papers?page=5